サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1287799

ポイントオブケアにおける分子診断市場：用途別、技術別、場所別、製品別、国別 - エグゼクティブガイドとカスタマイズ（2023年～2027年）

Molecular Diagnostics at the Point of Care. By Application, Technology, Place, Product and by Country. With Executive Guides and Customization 2023 - 2027
出版日: | 発行: Howe Sound Research | ページ情報: 英文 572 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.76円
ポイントオブケアにおける分子診断市場：用途別、技術別、場所別、製品別、国別 - エグゼクティブガイドとカスタマイズ（2023年～2027年）
出版日: 2023年06月05日
発行: Howe Sound Research
ページ情報: 英文 572 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートは、世界のポイントオブケアにおける分子診断市場について調査し、市場の概要とともに、用途別、技術別、場所別、製品別、国別動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 市場ガイド

第2章 イントロダクションと市場の定義

第3章 計測、自動化、および診断の動向

  • 計測と自動化

第4章 業界の概要

  • 市場参入組織
    • 学術研究機関
    • 診断試験開発者
    • 計装サプライヤー
    • 薬品・試薬メーカー
    • 病理サプライヤー
    • 独立系臨床検査室
    • 公共の国立/地域研究所
    • 病院検査室
    • 臨床検査室
    • 監査機関
    • 認証機関
  • 臨床検査市場セグメント
  • 産業構造

第5章 主要なMDx企業のプロファイル

  • Abacus Diagnostica
  • Abbott Laboratories
  • Accelerate Diagnostics
  • Access Bio
  • Ador Diagnostics
  • ADT Biotech
  • Akonni Biosystems
  • Alveo Technologies
  • Anitoa
  • Antelope Dx
  • Applied BioCode
  • Aureum Diagnostics
  • Aus Diagnostics
  • Autonomous Medical Devices
  • Baebies
  • Beckman Coulter Diagnostics
  • Becton, Dickinson and Company
  • Binx Health
  • Biocartis
  • BioFire Diagnostics（bioM?rieux）
  • bioM?rieux Diagnostics
  • Bio-Rad Laboratories, Inc
  • Bosch Healthcare Solutions GmbH
  • Cepheid（Danaher）
  • Credo Diagnostics Biomedical
  • Cue Health
  • Curetis N.V./Curetis GmbH
  • Detect
  • Diagenode Diagnostics
  • Diasorin S.p.A.
  • Domus Diagnostics
  • Enzo Biochem
  • Eurofins Scientific
  • Fluxergy
  • Fusion Genomics.
  • Genedrive
  • Genetic Signatures
  • GenMark Dx（Roche）
  • Genomadix
  • Getlabs
  • Grip Molecular Technologies
  • Hibergene Diagnostics
  • Hologic
  • Immunexpress
  • Inflammatix
  • Invetech
  • Iollo
  • Janssen Diagnostics
  • Karius
  • LightDeck Diagnostics
  • Lucira Health
  • Luminex Corp（DiaSorin）
  • LumiraDx
  • Maxim Biomedical
  • Meridian Bioscience
  • Mesa Biotech（Thermo Fisher）
  • MicroGem
  • Millipore Sigma
  • Minute Molecular
  • Mobidiag（Hologic）
  • Molbio Diagnostics
  • NanoDx
  • Nanomix
  • Novacyt
  • Novel Microdevices
  • OnsiteGene
  • Operon
  • Oxford Nanopore Technologies
  • Panagene
  • Perkin Elmer
  • Prenetics
  • Primerdesign（Novacyt）
  • Prominex
  • Proof Diagnostics
  • Qiagen
  • QuantuMDx
  • QuidelOrtho
  • Roche Molecular Diagnostics
  • Salignostics
  • Saw Diagnostics
  • SD Biosensor
  • Seegene
  • Siemens Healthineers
  • Sona Nanotech
  • SpeeDx
  • T2 Biosystems
  • Talis Biomedical
  • Thermo Fisher Scientific Inc.
  • Veramarx
  • XCR Diagnostics
  • Zhejiang Orient Gene Biotech

第6章 市場動向

  • 成長促進要因
  • 成長抑制要因

第7章 分子診断-感染症の最近の動向

第8章 世界のポイントオブケアにおける分子診断市場

  • 世界市場概要、国別
  • 世界市場- 概要、用途別
  • 世界市場- 概要、技術別
  • 世界市場- 概要、場所別
  • 世界市場- 概要、製品別

第9章 世界のポイントオブケアにおける分子診断市場-用途別

  • 呼吸器感染症
  • 消化器感染症
  • 性感染症
  • その他

第10章 世界のポイントオブケアにおける分子診断市場- 技術別

  • PCR
  • NGS/プローブ
  • その他

第11章 世界のポイントオブケアにおける分子診断市場-場所別

  • 病院のポイントオブケア
  • クリニックまたは診療所の検査室
  • 高齢者施設
  • その他

第12章 世界のポイントオブケアにおける分子診断市場-製品別

  • 装置
  • カートリッジ
  • その他

第13章 付録

図表

Table of Tables

  • Table 1: Seven Key Diagnostic Laboratory Technology Trends
  • Table 2: Market Players by Type
  • Table 3: Clinical Laboratory Departments and Segments
  • Table 4: Laboratory Management Focus - Different Approaches
  • Table 5: Key Segmentation Variables Going Forward
  • Table 6: Five Factors Driving Growth
  • Table 7: Four Factors Limiting Growth
  • Table 8: Global Market by Region
  • Table 9: Global Market by Application
  • Table 10: Global Market by Technology
  • Table 11: Global Market by Place
  • Table 12: Global Market by Product
  • Table 13: Respiratory Infectious Disease by Country
  • Table 14: Gastrointestinal Infectious Disease by Country
  • Table 15: Sexually Transmitted Disease by Country
  • Table 16: Other Application by Country
  • Table 17: PCR by Country
  • Table 18: NGS/Probe by Country
  • Table 19: Other Technology by Country
  • Table 20: Hospital Point of Care by Country
  • Table 21: Clinic or Physician Office Lab by Country
  • Table 22: Seniors Facility by Country
  • Table 23: Other Place by Country
  • Table 24: Instrument by Country
  • Table 25: Cartridge by Country
  • Table 26: Other Product by Country
  • Table 27: Clinical Lab Fee Schedule
  • Table 28: The Most Common Assays
  • Table 29: Largest Revenue Assays

Table of Figures

  • Figure 1: Global Health Spending
  • Figure 2: The Lab Test Pie
  • Figure 3: Centralized vs. Decentralized Laboratory Service
  • Figure 4: A Highly Multiplexed Syndromic Testing Unit
  • Figure 5: The Real Cost to Sequence the Human Genome
  • Figure 6: The Codevelopment Process
  • Figure 7: The Road to Diagnostics
  • Figure 8: Percentage of World Population Over 65
  • Figure 9: Chart Infectious Disease Decline
  • Figure 10: Global Market Shares Chart
  • Figure 11: Global Market by Application - Base vs. Final
  • Figure 12: Global Market by Application Base Year
  • Figure 13: Global Market by Application End Year
  • Figure 14: Application Share by Year
  • Figure 15: Application Segments Growth
  • Figure 16: Global Market by Technology - Base vs. Final
  • Figure 17: Global Market by Technology Base Year
  • Figure 18: Global Market by Technology End Year
  • Figure 19: Technology Share by Year
  • Figure 20: Technology Segments Growth
  • Figure 21: Global Market by Place - Base vs. Final
  • Figure 22: Global Market by Place Base Year
  • Figure 23: Global Market by Place End Year
  • Figure 24: Place Share by Year
  • Figure 25: Place Segments Growth
  • Figure 26: Global Market by Product - Base vs. Final
  • Figure 27: Global Market by Product Base Year
  • Figure 28: Global Market by Product End Year
  • Figure 29: Product Share by Year
  • Figure 30: Product Segments Growth
  • Figure 31: Respiratory Infectious Disease Diagnostics Growth
  • Figure 32: Gastrointestinal Infectious Disease Growth
  • Figure 33: Sexually Transmitted Disease Growth
  • Figure 34: Other Application Growth
  • Figure 35: PCR Growth
  • Figure 36: NGS/Probe Growth
  • Figure 37: Other Technology Growth
  • Figure 38: Hospital Point of Care Growth
  • Figure 39: Clinic or Physician Office Lab Growth
  • Figure 40: Seniors Facility Growth
  • Figure 41: Other Place Growth
  • Figure 42: Instrument Growth
  • Figure 43: Cartridge Growth
  • Figure 44: Other Product Growth
目次

OVERVIEW:

Can a rapidly growing market expand even faster? Find out all about it in this comprehensive report on Molecular Diagnostics at the Point of Care.

Are targeted tests for specific pathogens going to be obsolete? Will diagnostics replace physicians? Will Point of Care testing move into the Physician's Office or even the Home?

Point of Care testing is proving itself in the market. Players are reporting double digit growth. Lowering costs, improving outcomes and even helping in the battle against Anti Microbial Resistance. Learn about this market including the issues and outlooks. The two key trends of Point of Care Testing and Molecular Diagnostics are merging with spectacular success. It could possibly displace most frontline test protocols AND save money at the same time. The report forecasts the market size out for five years.

All report data is available in Excel format on request.

Make investment decisions and valuations with confidence using the latest data.

ABOUT THE LEAD AUTHOR:

Mr. Greg Powell, B.SC., M.B.A is the President of Howe Sound Research. He is an experienced business and clinical professional. He is co-author of the paper "The Radioimmunoassay of Angiotensinogen by Antibody Trapping." He has worked in laboratory testing and management for over 20 years. Mr. Powell's education includes:

  • B.Sc. (Chemistry) University of BC
  • M.B.A. (Finance and Policy) University of BC
  • Market Research Seminar - Burke Institute
  • Finance for Senior Executives - Harvard Business School

Table of Contents

1. Market Guides

  • 1.1. Strategic Situation Analysis
  • 1.2. Guide for Executives, Marketing and Business Development Staff
  • 1.3. Guide for Management Consultants and Investment Advisors

2. Introduction and Market Definition

  • 2.1. What are Molecular Diagnostics at the Point of Care?
  • 2.2. The Diagnostics Revolution
  • 2.3. Market Definition
    • 2.3.1. Revenues
  • 2.4. Methodology
    • 2.4.1. Methodology
    • 2.4.2. Sources
    • 2.4.3. Authors
  • 2.5. Perspective: Healthcare and the IVD Industry
    • 2.5.1. Global Healthcare Spending
    • 2.5.2. Spending on Diagnostics
    • 2.5.3. Important Role of Insurance for Diagnostics

3. Instrumentation, Automation and Diagnostic Trends

  • 3.1. Instrumentation and Automation
    • 3.1.1. Traditional Automation and Centralization
    • 3.1.2. The New Automation, Decentralization and Point Of Care
    • 3.1.3. Instruments Key to Market Share
    • 3.1.4. Bioinformatics Plays a Role
    • 3.1.5. PCR Takes Command
    • 3.1.6. Next Generation Sequencing Fuels a Revolution
    • 3.1.7. NGS Impact on Pricing
    • 3.1.8. Whole Genome Sequencing, A Brave New World
    • 3.1.9. Companion Diagnostics Blurs Diagnosis and Treatment

4. Industry Overview

  • 4.1. Players in a Dynamic Market
    • 4.1.1. Academic Research Lab
    • 4.1.2. Diagnostic Test Developer
    • 4.1.3. Instrumentation Supplier
    • 4.1.4. Chemical/Reagent Supplier
    • 4.1.5. Pathology Supplier
    • 4.1.6. Independent Clinical Laboratory
    • 4.1.7. Public National/regional Laboratory
    • 4.1.8. Hospital Laboratory
    • 4.1.9. Physicians Office Lab (POLS)
    • 4.1.10. Audit Body
    • 4.1.11. Certification Body
  • 4.2. The Clinical Laboratory Market Segments
    • 4.2.1. Traditional Market Segmentation
    • 4.2.2. Laboratory Focus and Segmentation
  • 4.3. Industry Structure
    • 4.3.1. Hospital Testing Share
    • 4.3.2. Economies of Scale
      • 4.3.2.1. Hospital vs. Central Lab
    • 4.3.3. Physician Office Lab's
    • 4.3.4. Physician's and POCT

5. Profiles of Key MDx Companies

  • 5.1. Abacus Diagnostica
  • 5.2. Abbott Laboratories
  • 5.3. Accelerate Diagnostics
  • 5.4. Access Bio
  • 5.5. Ador Diagnostics
  • 5.6. ADT Biotech
  • 5.7. Akonni Biosystems
  • 5.8. Alveo Technologies
  • 5.9. Anitoa
  • 5.10. Antelope Dx
  • 5.11. Applied BioCode
  • 5.12. Aureum Diagnostics
  • 5.13. Aus Diagnostics
  • 5.14. Autonomous Medical Devices
  • 5.15. Baebies
  • 5.16. Beckman Coulter Diagnostics
  • 5.17. Becton, Dickinson and Company
  • 5.18. Binx Health
  • 5.19. Biocartis
  • 5.20. BioFire Diagnostics (bioMérieux)
  • 5.21. bioMérieux Diagnostics
  • 5.22. Bio-Rad Laboratories, Inc
  • 5.23. Bosch Healthcare Solutions GmbH
  • 5.24. Cepheid (Danaher)
  • 5.25. Credo Diagnostics Biomedical
  • 5.26. Cue Health
  • 5.27. Curetis N.V. / Curetis GmbH
  • 5.28. Detect
  • 5.29. Diagenode Diagnostics
  • 5.30. Diasorin S.p.A.
  • 5.31. Domus Diagnostics
  • 5.32. Enzo Biochem
  • 5.33. Eurofins Scientific
  • 5.34. Fluxergy
  • 5.35. Fusion Genomics.
  • 5.36. Genedrive
  • 5.37. Genetic Signatures
  • 5.38. GenMark Dx (Roche)
  • 5.39. Genomadix
  • 5.40. Getlabs
  • 5.41. Grip Molecular Technologies
  • 5.42. Hibergene Diagnostics
  • 5.43. Hologic
  • 5.44. Immunexpress
  • 5.45. Inflammatix
  • 5.46. Invetech
  • 5.47. Iollo
  • 5.48. Janssen Diagnostics
  • 5.49. Karius
  • 5.50. LightDeck Diagnostics
  • 5.51. Lucira Health
  • 5.52. Luminex Corp (DiaSorin)
  • 5.53. LumiraDx
  • 5.54. Maxim Biomedical
  • 5.55. Meridian Bioscience
  • 5.56. Mesa Biotech (Thermo Fisher)
  • 5.57. MicroGem
  • 5.58. Millipore Sigma
  • 5.59. Minute Molecular
  • 5.60. Mobidiag (Hologic)
  • 5.61. Molbio Diagnostics
  • 5.62. NanoDx
  • 5.63. Nanomix
  • 5.64. Novacyt
  • 5.65. Novel Microdevices
  • 5.66. OnsiteGene
  • 5.67. Operon
  • 5.68. Oxford Nanopore Technologies
  • 5.69. Panagene
  • 5.70. Perkin Elmer
  • 5.71. Prenetics
  • 5.72. Primerdesign (Novacyt)
  • 5.73. Prominex
  • 5.74. Proof Diagnostics
  • 5.75. Qiagen
  • 5.76. QuantuMDx
  • 5.77. QuidelOrtho
  • 5.78. Roche Molecular Diagnostics
  • 5.79. Salignostics
  • 5.80. Saw Diagnostics
  • 5.81. SD Biosensor
  • 5.82. Seegene
  • 5.83. Siemens Healthineers
  • 5.84. Sona Nanotech
  • 5.85. SpeeDx
  • 5.86. T2 Biosystems
  • 5.87. Talis Biomedical
  • 5.88. Thermo Fisher Scientific Inc.
  • 5.89. Veramarx
  • 5.90. XCR Diagnostics
  • 5.91. Zhejiang Orient Gene Biotech

6. Market Trends

  • 6.1. Factors Driving Growth
    • 6.1.1. New Genotypes Creating New Markets
    • 6.1.2. Aging Population a Boon for All Diagnostics
    • 6.1.3. Developing World Driving ID Dx Growth
    • 6.1.4. Point of Care - Why Centralization is Losing Steam
    • 6.1.5. Self Testing
    • 6.1.6. The Need for Speed
  • 6.2. Factors Limiting Growth
    • 6.2.1. Lower Costs
    • 6.2.2. Infectious Disease is Declining
    • 6.2.3. Wellness Hurts
    • 6.2.4. Economic Growth improves Living Standards

7. Molecular Dx - Infectious Disease Recent Developments

  • 7.1. Recent Developments - Importance and How to Use This Section
    • 7.1.1. Importance of These Developments
    • 7.1.2. How to Use This Section
  • 7.2. Domus Diagnostics Wins NIH RADx Tech Contract
  • 7.3. Llusern Scientific to Launch POC MDx UTI Panel
  • 7.4. Altratech Enters POC MDx Testing Space with Unique Tech
  • 7.5. BioMérieux SpotFire MDx POC System Leverages Novel Approach
  • 7.6. Katalyst Labs to Distribute ProtonDx Dragonfly Rapid IVD System
  • 7.7. LEX Diagnostics Developing Ultra-Fast Low-Cost PCR
  • 7.8. Sherlock Biosciences Adds to Infectious Disease Dx Toolkit
  • 7.9. NanoDx Prepares for Point-of-Care Commercialization
  • 7.10. Paragraf to Study New POC Test to Guide Antibiotic Selection
  • 7.11. MicroGEM to Expand 30-Minute RT-PCR System
  • 7.12. Startup Detect to Roll Out Next-Gen Molecular Instrument
  • 7.13. Diagnostics for the Real World Third-Generation POC Platform
  • 7.14. Salignostics Closes Funding Round
  • 7.15. Cue Health Targets DTC Market in 2022
  • 7.16. Grip Molecular Developing Home Respiratory Panel
  • 7.17. Mainz Biomed Developing Home ColoAlert Assay
  • 7.18. MFB Fertility Closes Series A Financing Round
  • 7.19. Home Test Company Prenetics to go Public
  • 7.20. Roche to Acquire TIB Molbiol to Expand Infectious Disease Portfolio
  • 7.21. BforCure Preparing Multiple Panels for Point-of-Care qPCR Platform
  • 7.22. Talis Biomedical Discusses Point-of-Care
  • 7.23. Roche to Acquire GenMark Diagnostics for $1.8B
  • 7.24. Pandemic Pushes Handheld qPCR Devices Closer to Commercialization
  • 7.25. Hologic to Acquire Mobidiag
  • 7.26. Lucira Health Focuses on User Friendly Approach to Home Testing
  • 7.27. Infectious Disease Dx Firm Talis Biomedical Raises $254M in IPO
  • 7.28. Fluidigm Plans 'Durable' Diagnostics, Clinical Business
  • 7.29. Thermo Fisher Scientific to Acquire Mesa Biotech for Up to $550M
  • 7.30. Mammoth Biosciences Developing Pathogen Detection Tech
  • 7.31. Illumina, IDbyDNA Developing Sequencing-Based Respiratory Tests
  • 7.32. Scanogen Developing 90 Minute Infection Test
  • 7.33. Malaria Assays Use CRISPR for Point-of-Care Multispecies Detection
  • 7.34. FDA Provides Self Testing SARS-CoV-2 EAU Guidance
  • 7.35. Mammoth Biosciences Announces Rapid, CRISPR-Based COVID-19 Diagnostic
  • 7.36. Genetic Signatures Gets CE Mark for Coronavirus Molecular Test
  • 7.37. Qiagen Respiratory Panel with Coronavirus Receives CE Mark
  • 7.38. Lumos Diagnostics Closes $15M Series A Funding

8. The Global Market for Molecular Diagnostics at the Point of Care

  • 8.1. Global Market Overview by Country
    • 8.1.1. Table - Global Market by Country
    • 8.1.2. Chart-Global Market by Country
  • 8.2. Global Market by Application-Overview
    • 8.2.1. Table - Global Market by Application
    • 8.2.2. Chart - Global Market by Application - Base/Final Year Comparison
    • 8.2.3. Chart - Global Market by Application - Base Year
    • 8.2.4. Chart - Global Market by Application - End Year
    • 8.2.5. Chart - Global Market by Application - Share by Year
    • 8.2.6. Chart - Global Market by Application - Segments Growth
  • 8.3. Global Market by Technology-Overview
    • 8.3.1. Table - Global Market by Technology
    • 8.3.2. Chart - Global Market by Technology - Base/Final Year Comparison
    • 8.3.3. Chart - Global Market by Technology - Base Year
    • 8.3.4. Chart - Global Market by Technology - End Year
    • 8.3.5. Chart - Global Market by Technology - Share by Year
    • 8.3.6. Chart - Global Market by Technology - Segments Growth
  • 8.4. Global Market by Place-Overview
    • 8.4.1. Table - Global Market by Place
    • 8.4.2. Chart - Global Market by Place - Base/Final Year Comparison
    • 8.4.3. Chart - Global Market by Place - Base Year
    • 8.4.4. Chart - Global Market by Place - End Year
    • 8.4.5. Chart - Global Market by Place - Share by Year
    • 8.4.6. Chart - Global Market by Place - Segments Growth
  • 8.5. Global Market by Product-Overview
    • 8.5.1. Table - Global Market by Product
    • 8.5.2. Chart - Global Market by Product - Base/Final Year Comparison
    • 8.5.3. Chart - Global Market by Product - Base Year
    • 8.5.4. Chart - Global Market by Product - End Year
    • 8.5.5. Chart - Global Market by Product - Share by Year
    • 8.5.6. Chart - Global Market by Product - Segments Growth

9. Global MDx at the Point of Care Markets - By Application

  • 9.1. Respiratory Infectious Disease
    • 9.1.1. Table Respiratory Infectious Disease - by Country
    • 9.1.2. Chart-Respiratory Infectious Disease Growth
  • 9.2. Gastrointestinal Infectious Disease
    • 9.2.1. Table Gastrointestinal Infectious Disease - by Country
    • 9.2.2. Chart-Gastrointestinal Infectious Disease Growth
  • 9.3. Sexually Transmitted Disease
    • 9.3.1. Table Sexually Transmitted Disease - by Country
    • 9.3.2. Chart-Sexually Transmitted Disease Growth
  • 9.4. Other Application
    • 9.4.1. Table Other Application - by Country
    • 9.4.2. Chart-Other Application Growth

10. Global MDx Markets at the Point of Care - by Technology

  • 10.1. PCR
    • 10.1.1. Table PCR - by Country
    • 10.1.2. Chart-PCR Growth
  • 10.2. NGS/Probe
    • 10.2.1. Table NGS/Probe - by Country
    • 10.2.2. Chart-NGS/Probe Growth
  • 10.3. Other Technology
    • 10.3.1. Table Other Technology - by Country
    • 10.3.2. Chart-Other Technology Growth

11. Global MDx at the Point of Care Markets - by Place

  • 11.1. Hospital Point of Care
    • 11.1.1. Table Hospital Point of Care - by Country
    • 11.1.2. Chart-Hospital Point of Care Growth
  • 11.2. Clinic or Physician Office Lab
    • 11.2.1. Table Clinic or Physician Office Lab - by Country
    • 11.2.2. Chart-Clinic or Physician Office Lab Growth
  • 11.3. Seniors Facility
    • 11.3.1. Table Seniors Facility - by Country
    • 11.3.2. Chart - Seniors Facility Growth
  • 11.4. Other Place
    • 11.4.1. Table Other Place- by Country
    • 11.4.2. Chart - Other Place Growth

12. Global MDx at the Point of Care Markets - by Product

  • 12.1. Instrument
    • 12.1.1. Table Instrument - by Country
    • 12.1.2. Chart-Instrument Growth
  • 12.2. Cartridge
    • 12.2.1. Table Cartridge - by Country
    • 12.2.2. Chart-Cartridge Growth
  • 12.3. Other Product
    • 12.3.1. Table Other Product - by Country
    • 12.3.2. Chart - Other Product Growth

13. Appendices

  • 13.1. United States Medicare System: Clinical Laboratory Fees Schedule
  • 13.2. The Most Used IVD Assays
  • 13.3. The Highest Grossing Assays